About nine months ago, IBM (NYSE:IBM) made a very key strategic acquisition. No, it was not Merge Healthcare Inc. or even the more recent Truven Health Analytics. It was Deborah DiSanzo, General Manager for IBM Watson Health.
Watson Health stands out among CEO Ginny Rometty's several strategic imperatives because it is changing and facilitating healthcare systems not only in developed countries but in emerging markets as well, on a massive scale.
The urgent need for better, more transparent and more efficient healthcare systems around the world - even in the United States - puts Watson Health in an enviable position. And Deborah DiSanzo has been hand-picked by Rometty to drive IBM's vision forward in the healthcare analytics space.
